Chen Hongming 4
4 · Kala Pharmaceuticals, Inc. · Filed Jan 4, 2019
Insider Transaction Report
Form 4
Chen Hongming
Chief Scientific Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2019-01-02+150,000→ 150,000 totalExercise: $5.19Exp: 2029-01-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 2, 2019 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter.